Prothena Corporation plc (PRTA) financial statements (2020 and earlier)

Company profile

Business Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C
DUBLIN 2, D02 T804
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments376428418387371294177
Cash and cash equivalents376428418387371294177
Receivables0000120
Deferred costs      (0)
Other current assets3      
Other undisclosed current assets 484642
Total current assets:378431426391377299178
Noncurrent Assets
Operating lease, right-of-use asset23
Property, plant and equipment4535556433
Restricted cash and investments3 44   
Other noncurrent assets11321  
Other undisclosed noncurrent assets101486321
Total noncurrent assets:41677069854
TOTAL ASSETS:419499496460385304182
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities121413595
Accounts payable111413552
Accrued liabilities     1 
Employee-related liabilities     33
Taxes payable0000 00
Debt5      
Restructuring reserve 0    
Other liabilities6699554
Other undisclosed current liabilities67141913(2)(1)
Total current liabilities:1815374122127
Noncurrent Liabilities
Long-term debt and lease obligation18      
Operating lease, liability18
Liabilities, other than long-term debt111102222
Deferred revenue and credits02222
Accounts payable and accrued liabilities   000 
Deferred revenue110
Deferred rent credit 0
Other liabilities11  0  
Other undisclosed noncurrent liabilities 1605251   
Total noncurrent liabilities:1291615253222
Total liabilities:146176899525149
Stockholders' equity
Stockholders' equity attributable to parent273323407365361290173
Common stock0000000
Additional paid in capital944921849654489338214
Accumulated deficit(672)(598)(442)(289)(129)(48)(41)
Total stockholders' equity:273323407365361290173
TOTAL LIABILITIES AND EQUITY:419499496460385304182

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenue, net   11
Sublease income3
Gross profit:112812511
Operating expenses(87)(160)(183)(161)(82)(58)(41)
Operating loss:(86)(159)(155)(160)(80)(7)(40)
Nonoperating income (expense)83(2)100(0)
Investment income, nonoperating    000
Other nonoperating income (expense)00(2)0(0)0(0)
Loss from continuing operations before income taxes:(77)(156)(158)(159)(80)(6)(41)
Income tax expense (benefit)(0)04(1)(1)(1)(0)
Net loss available to common stockholders, diluted:(78)(156)(153)(160)(81)(7)(41)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(78)(156)(153)(160)(81)(7)(41)
Comprehensive loss, net of tax, attributable to parent:(78)(156)(153)(160)(81)(7)(41)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: